Filing Details
- Accession Number:
- 0001209191-21-032100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-12 13:00:00
- Reporting Period:
- 2021-05-11
- Accepted Time:
- 2021-05-12 17:03:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
718937 | Staar Surgical Co | STAA | Ophthalmic Goods (3851) | 953797439 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1781933 | C. Graydon Hansen | 25651 Atlantic Ocean Drive Lake Forest CA 92630 | Sr. Vp, Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-11 | 1,050 | $35.98 | 15,428 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-05-11 | 10,025 | $27.53 | 25,453 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-11 | 11,075 | $111.61 | 14,378 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-05-12 | 5,531 | $110.74 | 8,847 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 375 | $29.80 | 9,222 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 231 | $35.98 | 9,453 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 348 | $16.15 | 9,801 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Options | Disposition | 2021-05-11 | 1,050 | $0.00 | 1,050 | $35.98 |
Common Stock | Common Stock Options | Disposition | 2021-05-11 | 10,025 | $0.00 | 10,025 | $27.53 |
Common Stock | Common Stock Options | Disposition | 2021-05-12 | 375 | $0.00 | 375 | $29.80 |
Common Stock | Common Stock Options | Disposition | 2021-05-12 | 231 | $0.00 | 231 | $35.98 |
Common Stock | Common Stock Options | Disposition | 2021-05-12 | 348 | $0.00 | 348 | $16.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,272 | 2020-03-14 | 2029-03-13 | No | 4 | M | Direct |
17,737 | 2021-03-20 | 2030-03-19 | No | 4 | M | Direct |
375 | 2019-06-14 | 2028-06-13 | No | 4 | M | Direct |
7,041 | 2020-03-14 | 2029-03-13 | No | 4 | M | Direct |
0 | 2019-03-15 | 2028-03-14 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.08 to $113.18, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $112.29, inclusive.
- The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
- The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.
- The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021.
- The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021.